<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; the Intermezzo NDA review</title>
	<atom:link href="http://www.straightstocks.com/tag/the-intermezzo-nda-review/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Sun, 21 Mar 2010 12:30:43 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>FDA Calendar Updates: BDSI, SVNT Deadlines Approach</title>
		<link>http://www.straightstocks.com/financial/fda-calendar-updates-bdsi-svnt-deadlines-approach/</link>
		<comments>http://www.straightstocks.com/financial/fda-calendar-updates-bdsi-svnt-deadlines-approach/#comments</comments>
		<pubDate>Sun, 21 Jun 2009 16:00:59 +0000</pubDate>
		<dc:creator>Bullish Bankers</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[3Q09;]]></category>
		<category><![CDATA[Arthritis Advisory Committee]]></category>
		<category><![CDATA[BENLYSTA]]></category>
		<category><![CDATA[breakthrough cancer pain;]]></category>
		<category><![CDATA[bullish bankers]]></category>
		<category><![CDATA[Commission of European Communities;]]></category>
		<category><![CDATA[drug delivery]]></category>
		<category><![CDATA[Drug Delivery Technology]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fentanyl;]]></category>
		<category><![CDATA[Glaxosmithkline]]></category>
		<category><![CDATA[Glaxosmithkline Plc]]></category>
		<category><![CDATA[gout]]></category>
		<category><![CDATA[human collagen technology]]></category>
		<category><![CDATA[Intermezzo]]></category>
		<category><![CDATA[lupus;]]></category>
		<category><![CDATA[Meda Ab]]></category>
		<category><![CDATA[ONSOLIS;]]></category>
		<category><![CDATA[original author]]></category>
		<category><![CDATA[serious infections]]></category>
		<category><![CDATA[SLE;]]></category>
		<category><![CDATA[south korea]]></category>
		<category><![CDATA[systemic lupus erythematosus;]]></category>
		<category><![CDATA[Taiwan]]></category>
		<category><![CDATA[the Intermezzo NDA review]]></category>
		<category><![CDATA[the NDA review]]></category>
		<category><![CDATA[treatment of breakthrough cancer]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[zolpidem tartrate]]></category>

		<guid isPermaLink="false">http://www.bullishbankers.com/?p=14494</guid>
		<description><![CDATA[Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/financial/fda-calendar-updates-bdsi-svnt-deadlines-approach/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
